ImmunoGen vs ONA Therapeutics
ImmunoGen
Focusing on core therapeutic areas such as immunology, oncology, neuroscience, eye care, aesthetics, and other areas of unmet need
34 employees · est. 1981
ONA Therapeutics
First-in-class ADCs tailored to attack advanced cancer
43 employees · est. 2019 · Barcelona, Spain
ImmunoGen is the older company (1981 vs 2019).
Side-by-Side Comparison
| Metric | ImmunoGen | ONA Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 1981 older | 2019 |
| Headquarters | ||
| Headquarters | Not tracked yet | Barcelona, Spain |
| Employees | ||
| Employees | 34 | 43 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Acquired | Series A |
| Total Funding | ||
| Total Funding | $681.30M | $31.50M |
| Funding Rounds | ||
| Funding Rounds | 11 | 2 |
| Services | ||
| Services | Drug Development, Clinical Trials Management, Cancer Research and Treatment Solutions, Healthcare Professional Support | Development of first-in-class ADCs, Identification of novel cancer therapeutic targets, Biologics engineering and customization, Clinical development and trials |
| Target Customers | ||
| Target Customers | Cancer Patients, Oncologists, Healthcare Providers, Research Institutions | Advanced cancer patients, Clinical research institutions, Healthcare providers specializing in oncology, Pharmaceutical companies focusing on cancer treatments |
| Taxonomy | ||
| Taxonomy | Antibody-drug ConjugatesCancer TreatmentOncologyImmunologyNeuroscienceTherapeutics Development +6 | Antibody Drug ConjugatesBiologics DevelopmentCancer TherapeuticsMetastatic CancerAdvanced CancerTherapeutic Biologics +7 |
| Website | ||
| Website | immunogen.com | ona-therapeutics.com |
About ImmunoGen
ImmunoGen, Inc. is a biotechnology innovator, harnessing the potential of antibody-drug conjugates (ADCs) to revolutionize cancer treatment. With a focus on oncology, the company combines the precision of antibodies with the effectiveness of cytotoxic drugs, aiming to target cancer cells while spari...
About ONA Therapeutics
ONA Therapeutics, founded in 2019 and based in Spain, is at the forefront of developing innovative solutions in the Biotechnology, Health Care, and Life Sciences industries. Utilizing their expertise in biologics, they specialize in creating first-in-class antibody drug conjugates (ADCs) designed to...
Also comparing in this category
Comparing more than these two?
Get ImmunoGen, ONA Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ImmunoGen compare?
A PDF of ImmunoGen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare ImmunoGen with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ImmunoGen on 10 Jun 2026, and ONA Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
